| | Class 2 Device Recall CADD Yellow Medication Cassette Reservoir with NRFit Connector |  |
| Date Initiated by Firm | August 20, 2026 |
| Date Posted | September 17, 2026 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-3212-2026 |
| Recall Event ID |
99648 |
| 510(K)Number | K162219 |
| Product Classification |
Set, i.V. Fluid transfer - Product Code LHI
|
| Product | CADD Yellow Medication Cassette Reservoir with NRFit connector
US Product Codes: 21-7600-24, 21-7609-24
OUS Product Codes:
21-7609-24
21-7600-24
21-7600-24
21-7600-24
21-7609-24
21-7609-24
21-7600-24
21-7600-24
21-7609-24
21-7609-24
21-7600-24
21-7600-24
21-7609-24
21-7600-24
21-7600-24
21-7609-24
21-7609-24JP
21-7600-24JP
21-7609-24
21-7609-24
21-7600-24
21-7600-24
21-7609-24
21-7600-24
21-7600-24
21-7600-24
21-7609-24 |
| Code Information |
21-7600-24
UDI-DI 30610586044001
Lots 6026878
6037784
6054015
6062724
6070616
6082332
6092886
6101906
6108556
6126029
6140893
6143454
6147696
6147697
6162769
6155095
6166032
6171587
6171586
21-7609-24
UDI-DI 30610586044018
Lot 6022079
6037697
6037698
6053978
6061525
6072970
6072964
6070575
6077773
6092846
6101798
6108514
6108515
6108516
6140862
6140861
6140865
6155132
|
| FEI Number |
3013319212
|
Recalling Firm/ Manufacturer |
ICU Medical, Inc.
600 N Field Dr
Lake Forest
IL
60045-4835
|
| For Additional Information Contact | Customer Service 800-258-5361 |
Manufacturer Reason for Recall | Reservoirs may exhibit medication leakage at the joint between luer connector and tubing. Issue could result in delay or interruption of therapy, under delivery of medication, exposure to infectious or toxic agents, or air embolus. |
FDA Determined Cause 2 | Process control |
| Action | On August 20, 2026, the firm began notifying affected customers via Urgent Medical Device Correction letters. Customers were informed that certain reservoirs may exhibit fluid leakage at the joint between the connector and the tubing.
Customers were instructed to check all inventory locations for affected product and discontinue use. All affected products should be destroyed following their institution's destruction process. If destruction is not immediately possible at your facility, quarantine the products until disposal.
Customers should share the notification with all potential users of the reservoirs, and notify any accounts to whom the affected products have been further distributed.
The firm will provide replacement products to affected customers upon receipt of a completed Customer Response Form to certify product destruction. |
| Quantity in Commerce | 185,688 units |
| Distribution | Worldwide - US Nationwide distribution in the states of AR, CA, FL, IL, IN, LA, MI, MO, MS,
TN, TX, VA, WI and the countries of Austria, Australia, Belgium, Costa Rica, Germany, Estonia, Spain, Finland, France, Great Britain, Ireland, Italy, Japan, Kuwait, Netherlands, Norway, and Sweden. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
| 510(K) Database | 510(K)s with Product Code = LHI
|
|
|
|